These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32486167)

  • 1. Current Therapy in CKD Patients Can Affect Vitamin K Status.
    Cozzolino M; Cianciolo G; Podestà MA; Ciceri P; Galassi A; Gasperoni L; Manna G
    Nutrients; 2020 May; 12(6):. PubMed ID: 32486167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease.
    Levy DS; Grewal R; Le TH
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F618-F623. PubMed ID: 32830534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Vitamin K in Vascular Calcification.
    Cozzolino M; Fusaro M; Ciceri P; Gasperoni L; Cianciolo G
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):437-444. PubMed ID: 31831122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health.
    Bellone F; Cinquegrani M; Nicotera R; Carullo N; Casarella A; Presta P; Andreucci M; Squadrito G; Mandraffino G; Prunestì M; Vocca C; De Sarro G; Bolignano D; Coppolino G
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism.
    McCabe KM; Zelt JG; Kaufmann M; Laverty K; Ward E; Barron H; Jones G; Adams MA; Holden RM
    J Pharmacol Exp Ther; 2018 Sep; 366(3):433-445. PubMed ID: 29903718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone in CKD-mediated mineral and vascular disease.
    Khouzam NM; Wesseling-Perry K; Salusky IB
    Pediatr Nephrol; 2015 Sep; 30(9):1379-88. PubMed ID: 25168424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.
    Kaur R; Singh R
    Life Sci; 2022 Dec; 311(Pt B):121148. PubMed ID: 36336124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular calcification: a common but overlooked condition].
    Stenvinkel P
    Lakartidningen; 2013 May 22-28; 110(21):1041-4. PubMed ID: 23805771
    [No Abstract]   [Full Text] [Related]  

  • 11. Mineral bone disorders in chronic kidney disease.
    Hou YC; Lu CL; Lu KC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K role in mineral and bone disorder of chronic kidney disease.
    de Oliveira RB; Stinghen AEM; Massy ZA
    Clin Chim Acta; 2020 Mar; 502():66-72. PubMed ID: 31836502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone health and vascular calcification relationships in chronic kidney disease.
    Spasovski GB
    Int Urol Nephrol; 2007; 39(4):1209-16. PubMed ID: 17899431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
    Hu P; Xuan Q; Hu B; Lu L; Wang J; Qin YH
    Int J Biol Sci; 2012; 8(5):663-71. PubMed ID: 22606047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
    Grzejszczak P; Kurnatowska I
    Kidney Blood Press Res; 2021; 46(5):523-530. PubMed ID: 34247173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin K, bone metabolism and vascular calcification in chronic kidney disease].
    Zak-Gołab A; Okopień B; Chudek J
    Przegl Lek; 2011; 68(9):629-32. PubMed ID: 22335014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease.
    Shah A
    Panminerva Med; 2017 Jun; 59(2):124-132. PubMed ID: 28290186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.